Industry News
Vitamin B3, fiber 'protects against colon cancer and inflammation'
Jan 20, 2014
Previous research has suggested that a diet rich in fiber may reduce the risk of colon inflammation and cancer. But new research suggests that niacin, also known as vitamin B3, may also help protect against these conditions.The research team, including co-author Dr. Read More
Monoclonal antibody therapy enhances removal of circulating tumor cells
Jan 20, 2014
Monoclonal antibodies directed against tumor antigens have proven effective for treating some forms of cancer. Despite the increasing use of monoclonal antibody therapy, it is not clear how these antibodies drive tumor removal. Read More
Vitamin B3, fiber 'protects against colon cancer and inflammation'
Jan 20, 2014
Previous research has suggested that a diet rich in fiber may reduce the risk of colon inflammation and cancer. But new research suggests that niacin, also known as vitamin B3, may also help protect against these conditions.The research team, including co-author Dr. Read More
Application of global sequencing technology reveals how an activator of gene expression stays focused
Jan 19, 2014
At a glance, DNA is a rather simple sequence of A, G, C, T bases, but once it is packaged by histone proteins into an amalgam called chromatin, a more complex picture emerges. Histones, which come in four subtypes - H2A, H2B, H3, and H4 - can either coil DNA into inaccessible silent regions or untwist it to allow gene expression. Read More
Promising results of phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer
Jan 19, 2014
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. Read More
Coevolution between humans and bacteria found to reduce gastric cancer risk
Jan 19, 2014
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person's risk of disease. Working with colleagues in Columbia and the U.S. Read More
Fewer years of life lost to cancer
Jan 19, 2014
Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate - the historic benchmark of progress - has only declined modestly while the mortality rates of other leading causes of death have declined substantially. Read More
Promising results of phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer
Jan 19, 2014
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. Read More
Clarifying mode of action of a targeted treatment for leukemia
Jan 18, 2014
The mechanism of senescence - or premature cell ageing - can have an anticancer effect. This new work, conducted by Hugues de Thé and his team (Paris Diderot University/ Inserm/ CNRS/ AP-HP), was published in Nature Medicine. Read More
Potential treatment to improve heart health in hemodialysis patients
Jan 18, 2014
Researchers at Wayne State University have discovered a potential way to improve the lipid profiles in patients undergoing hemodialysis that may prevent cardiovascular disease common in these patients. Patients undergoing hemodialysis for kidney failure are at a greater risk for atherosclerosis, a common disease in which plaque builds up inside the arteries. Read More
Previous Page Next Page